2026 Q1 -tulosraportti
62 päivää sitten
‧29 min
17,00 DKK/osake
Viimeisin osinko
2,87%Tuotto/v
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 14.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 1.5. | ||
2025 Q4 -tulosraportti 5.3. | ||
2025 Q3 -tulosraportti 12.11.2025 | ||
2025 Q2 -tulosraportti 15.8.2025 | ||
2025 Q1 -tulosraportti 2.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·7 t sittenI actually became more positive on Schouw after this news. I had been curious how they would use the proceeds from BioMar. This looks like a disciplined first step: a profitable niche company with specialized competencies and an existing management that continues. It will be interesting to follow the development.
Schouw received approximately 3 billion in cash from the IPO of Biomar and they have bought back a good portion of their own shares, where they currently own 9.59% of them and will buy up further. Today's purchase in Spectre and having acquired a majority stake looks like a good buy and I think that before long we will surely see another acquisition of x-company or buying into a company with good development opportunities. It looks like one can buy in cheaply here, despite there always being a conglomerate discount in Schouw, but it looks like it's quite large right now..- ·3 päivää sittenWhat are the 2.8 billion bruds for? The stabilization period is over, and Schouw now has the money in the bank. The announcement is that the money will be used to strengthen the portfolio companies, or acquire a new one. An extra dividend is hardly on the table. We await with excitement!they will pay out 50 % of the profit, but that's precisely the question, how big will the profit be??
·17.6. · MuokattuSeveral writers have made calculations of the values in Schouw and shown that the Intrinsic Value per share is significantly greater than the share price. They then conclude that Schouw is too cheap! Well then. Has no one considered that the Intrinsic value is irrelevant with a management with their head under their arm. What is the value for shareholders in buying shares in Schouw at a price < Intrinsic value? Firstly, as a normal shareholder in Schouw, one cannot decide to sell the shares in the portfolio companies, so that the values can be paid out as cash to the shareholders. Secondly, a management can choose to use any sales proceeds for foolish acquisitions or initiatives. History suggests that Intrinsic value is irrelevant. It is earnings and trust in management's decisions that matter.
Schouw has not yielded a return in the last 5 years (-8%). According to management, the purpose of Biomar's IPO was to provide some share-holder value to the shareholders. It did not succeed; on the contrary, the share has fallen considerably after the IPO, and Biomar has been subject to significant support buying to maintain the issue price. This does not look good for Schouw's management.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
62 päivää sitten
‧29 min
17,00 DKK/osake
Viimeisin osinko
2,87%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·7 t sittenI actually became more positive on Schouw after this news. I had been curious how they would use the proceeds from BioMar. This looks like a disciplined first step: a profitable niche company with specialized competencies and an existing management that continues. It will be interesting to follow the development.Schouw received approximately 3 billion in cash from the IPO of Biomar and they have bought back a good portion of their own shares, where they currently own 9.59% of them and will buy up further. Today's purchase in Spectre and having acquired a majority stake looks like a good buy and I think that before long we will surely see another acquisition of x-company or buying into a company with good development opportunities. It looks like one can buy in cheaply here, despite there always being a conglomerate discount in Schouw, but it looks like it's quite large right now..
- ·3 päivää sittenWhat are the 2.8 billion bruds for? The stabilization period is over, and Schouw now has the money in the bank. The announcement is that the money will be used to strengthen the portfolio companies, or acquire a new one. An extra dividend is hardly on the table. We await with excitement!they will pay out 50 % of the profit, but that's precisely the question, how big will the profit be??
- ·17.6. · MuokattuSeveral writers have made calculations of the values in Schouw and shown that the Intrinsic Value per share is significantly greater than the share price. They then conclude that Schouw is too cheap! Well then. Has no one considered that the Intrinsic value is irrelevant with a management with their head under their arm. What is the value for shareholders in buying shares in Schouw at a price < Intrinsic value? Firstly, as a normal shareholder in Schouw, one cannot decide to sell the shares in the portfolio companies, so that the values can be paid out as cash to the shareholders. Secondly, a management can choose to use any sales proceeds for foolish acquisitions or initiatives. History suggests that Intrinsic value is irrelevant. It is earnings and trust in management's decisions that matter.Schouw has not yielded a return in the last 5 years (-8%). According to management, the purpose of Biomar's IPO was to provide some share-holder value to the shareholders. It did not succeed; on the contrary, the share has fallen considerably after the IPO, and Biomar has been subject to significant support buying to maintain the issue price. This does not look good for Schouw's management.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 14.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 1.5. | ||
2025 Q4 -tulosraportti 5.3. | ||
2025 Q3 -tulosraportti 12.11.2025 | ||
2025 Q2 -tulosraportti 15.8.2025 | ||
2025 Q1 -tulosraportti 2.5.2025 |
2026 Q1 -tulosraportti
62 päivää sitten
‧29 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 14.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 1.5. | ||
2025 Q4 -tulosraportti 5.3. | ||
2025 Q3 -tulosraportti 12.11.2025 | ||
2025 Q2 -tulosraportti 15.8.2025 | ||
2025 Q1 -tulosraportti 2.5.2025 |
17,00 DKK/osake
Viimeisin osinko
2,87%Tuotto/v
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·7 t sittenI actually became more positive on Schouw after this news. I had been curious how they would use the proceeds from BioMar. This looks like a disciplined first step: a profitable niche company with specialized competencies and an existing management that continues. It will be interesting to follow the development.Schouw received approximately 3 billion in cash from the IPO of Biomar and they have bought back a good portion of their own shares, where they currently own 9.59% of them and will buy up further. Today's purchase in Spectre and having acquired a majority stake looks like a good buy and I think that before long we will surely see another acquisition of x-company or buying into a company with good development opportunities. It looks like one can buy in cheaply here, despite there always being a conglomerate discount in Schouw, but it looks like it's quite large right now..
- ·3 päivää sittenWhat are the 2.8 billion bruds for? The stabilization period is over, and Schouw now has the money in the bank. The announcement is that the money will be used to strengthen the portfolio companies, or acquire a new one. An extra dividend is hardly on the table. We await with excitement!they will pay out 50 % of the profit, but that's precisely the question, how big will the profit be??
- ·17.6. · MuokattuSeveral writers have made calculations of the values in Schouw and shown that the Intrinsic Value per share is significantly greater than the share price. They then conclude that Schouw is too cheap! Well then. Has no one considered that the Intrinsic value is irrelevant with a management with their head under their arm. What is the value for shareholders in buying shares in Schouw at a price < Intrinsic value? Firstly, as a normal shareholder in Schouw, one cannot decide to sell the shares in the portfolio companies, so that the values can be paid out as cash to the shareholders. Secondly, a management can choose to use any sales proceeds for foolish acquisitions or initiatives. History suggests that Intrinsic value is irrelevant. It is earnings and trust in management's decisions that matter.Schouw has not yielded a return in the last 5 years (-8%). According to management, the purpose of Biomar's IPO was to provide some share-holder value to the shareholders. It did not succeed; on the contrary, the share has fallen considerably after the IPO, and Biomar has been subject to significant support buying to maintain the issue price. This does not look good for Schouw's management.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt